Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-03-20

Clinical Trial Update: Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level [Phase 4]

View source ↗

Summary

Phase 4 trial comparing simvastatin and rosuvastatin in systemic lupus erythematosus patients on corticosteroids with high LDL cholesterol, evaluating efficacy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)
  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Ramathibodi Hospital | Conditions: Systemic Lupus Erythematosus, High LDL Cholesterol Level | Phase 4 | Status: UNKNOWN